CN116063200A - A kind of isoxazoline pet insecticide Freilaner intermediate and preparation method thereof - Google Patents
A kind of isoxazoline pet insecticide Freilaner intermediate and preparation method thereof Download PDFInfo
- Publication number
- CN116063200A CN116063200A CN202211606668.1A CN202211606668A CN116063200A CN 116063200 A CN116063200 A CN 116063200A CN 202211606668 A CN202211606668 A CN 202211606668A CN 116063200 A CN116063200 A CN 116063200A
- Authority
- CN
- China
- Prior art keywords
- acetate
- sodium
- acid
- potassium
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000002917 insecticide Substances 0.000 title claims abstract description 19
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 title claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 48
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 18
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 13
- 238000007112 amidation reaction Methods 0.000 claims abstract description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 5
- 239000000575 pesticide Substances 0.000 claims abstract description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims abstract 9
- 239000011737 fluorine Substances 0.000 claims abstract 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 63
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 60
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 47
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 40
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 25
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 24
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 20
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 claims description 16
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 14
- 239000003960 organic solvent Substances 0.000 claims description 14
- AUHZEENZYGFFBQ-UHFFFAOYSA-N 1,3,5-trimethylbenzene Chemical compound CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 claims description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 12
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 12
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 12
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000002585 base Substances 0.000 claims description 11
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 10
- QWXYZCJEXYQNEI-OSZHWHEXSA-N intermediate I Chemical compound COC(=O)[C@@]1(C=O)[C@H]2CC=[N+](C\C2=C\C)CCc2c1[nH]c1ccccc21 QWXYZCJEXYQNEI-OSZHWHEXSA-N 0.000 claims description 10
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 10
- 235000011181 potassium carbonates Nutrition 0.000 claims description 10
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 10
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims description 8
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 8
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 8
- 229940090181 propyl acetate Drugs 0.000 claims description 8
- 230000035484 reaction time Effects 0.000 claims description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 8
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 8
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 8
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 7
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 6
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 6
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 6
- 125000001931 aliphatic group Chemical group 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 239000003999 initiator Substances 0.000 claims description 6
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 claims description 6
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 claims description 6
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 claims description 6
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 claims description 6
- 229940078552 o-xylene Drugs 0.000 claims description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims description 6
- WMOVHXAZOJBABW-UHFFFAOYSA-N tert-butyl acetate Chemical compound CC(=O)OC(C)(C)C WMOVHXAZOJBABW-UHFFFAOYSA-N 0.000 claims description 6
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 5
- 239000001488 sodium phosphate Substances 0.000 claims description 5
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 5
- 235000011008 sodium phosphates Nutrition 0.000 claims description 5
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 5
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 claims description 4
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- ZOAIGCHJWKDIPJ-UHFFFAOYSA-M caesium acetate Chemical compound [Cs+].CC([O-])=O ZOAIGCHJWKDIPJ-UHFFFAOYSA-M 0.000 claims description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 4
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 claims description 4
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 claims description 4
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 4
- 235000019797 dipotassium phosphate Nutrition 0.000 claims description 4
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 4
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 4
- 235000019800 disodium phosphate Nutrition 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 238000005658 halogenation reaction Methods 0.000 claims description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 4
- 229940071870 hydroiodic acid Drugs 0.000 claims description 4
- 235000011056 potassium acetate Nutrition 0.000 claims description 4
- 239000011736 potassium bicarbonate Substances 0.000 claims description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 4
- 239000011698 potassium fluoride Substances 0.000 claims description 4
- 235000003270 potassium fluoride Nutrition 0.000 claims description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 4
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 4
- 235000011009 potassium phosphates Nutrition 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- 239000001632 sodium acetate Substances 0.000 claims description 4
- 235000017281 sodium acetate Nutrition 0.000 claims description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims description 4
- 239000012312 sodium hydride Substances 0.000 claims description 4
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
- 239000004342 Benzoyl peroxide Substances 0.000 claims description 3
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 3
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 claims description 3
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical group COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 2
- 238000010511 deprotection reaction Methods 0.000 claims description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- NALMPLUMOWIVJC-UHFFFAOYSA-N n,n,4-trimethylbenzeneamine oxide Chemical compound CC1=CC=C([N+](C)(C)[O-])C=C1 NALMPLUMOWIVJC-UHFFFAOYSA-N 0.000 claims description 2
- 239000003791 organic solvent mixture Substances 0.000 claims description 2
- XUXNAKZDHHEHPC-UHFFFAOYSA-M sodium bromate Chemical compound [Na+].[O-]Br(=O)=O XUXNAKZDHHEHPC-UHFFFAOYSA-M 0.000 claims description 2
- 239000011697 sodium iodate Substances 0.000 claims description 2
- 235000015281 sodium iodate Nutrition 0.000 claims description 2
- 229940032753 sodium iodate Drugs 0.000 claims description 2
- 235000009518 sodium iodide Nutrition 0.000 claims description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 3
- 239000004215 Carbon black (E152) Substances 0.000 claims 2
- 239000003513 alkali Substances 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 229930195733 hydrocarbon Natural products 0.000 claims 2
- 229940086066 potassium hydrogencarbonate Drugs 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 229960003339 sodium phosphate Drugs 0.000 claims 2
- 239000000047 product Substances 0.000 abstract description 23
- BKYWPNROPGQIFZ-UHFFFAOYSA-M 2,4-dimethylbenzoate Chemical compound CC1=CC=C(C([O-])=O)C(C)=C1 BKYWPNROPGQIFZ-UHFFFAOYSA-M 0.000 abstract description 7
- 241001465754 Metazoa Species 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000031709 bromination Effects 0.000 abstract description 3
- 238000005893 bromination reaction Methods 0.000 abstract description 3
- AGOSGCWATIJZHQ-UHFFFAOYSA-N tert-butyl [(2-methylpropan-2-yl)oxycarbonylamino] carbonate Chemical compound CC(C)(C)OC(=O)NOC(=O)OC(C)(C)C AGOSGCWATIJZHQ-UHFFFAOYSA-N 0.000 abstract description 3
- 239000006227 byproduct Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 description 91
- 239000000543 intermediate Substances 0.000 description 65
- 239000002904 solvent Substances 0.000 description 40
- 239000000706 filtrate Substances 0.000 description 39
- 238000001914 filtration Methods 0.000 description 14
- 239000000376 reactant Substances 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 239000012043 crude product Substances 0.000 description 13
- 239000012299 nitrogen atmosphere Substances 0.000 description 13
- 239000011541 reaction mixture Substances 0.000 description 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 12
- 239000001257 hydrogen Substances 0.000 description 12
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 12
- 239000007789 gas Substances 0.000 description 11
- 238000010992 reflux Methods 0.000 description 11
- QQCLNRPRQRDMCK-UHFFFAOYSA-N methyl 2,4-dimethylbenzoate Chemical compound COC(=O)C1=CC=C(C)C=C1C QQCLNRPRQRDMCK-UHFFFAOYSA-N 0.000 description 10
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- MLBZKOGAMRTSKP-UHFFFAOYSA-N fluralaner Chemical compound C1=C(C(=O)NCC(=O)NCC(F)(F)F)C(C)=CC(C=2CC(ON=2)(C=2C=C(Cl)C=C(Cl)C=2)C(F)(F)F)=C1 MLBZKOGAMRTSKP-UHFFFAOYSA-N 0.000 description 6
- 229960004498 fluralaner Drugs 0.000 description 5
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- ACUOJJBRHCFOKT-UHFFFAOYSA-N 2-amino-n-(2,2,2-trifluoroethyl)acetamide Chemical compound NCC(=O)NCC(F)(F)F ACUOJJBRHCFOKT-UHFFFAOYSA-N 0.000 description 2
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000026030 halogenation Effects 0.000 description 2
- -1 isoxazoline compound Chemical class 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 2
- 229910000105 potassium hydride Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- UYBQBUZXULIDMQ-UHFFFAOYSA-N 1,3-dichloro-5-(3,3,3-trifluoroprop-1-en-2-yl)benzene Chemical compound FC(F)(F)C(=C)C1=CC(Cl)=CC(Cl)=C1 UYBQBUZXULIDMQ-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- LWNRBRVWBVQQIF-UHFFFAOYSA-N 4-acetyl-2-methylbenzonitrile Chemical compound CC(=O)C1=CC=C(C#N)C(C)=C1 LWNRBRVWBVQQIF-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 108010062745 Chloride Channels Proteins 0.000 description 1
- 102000011045 Chloride Channels Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000005915 GABA Receptors Human genes 0.000 description 1
- 108010005551 GABA Receptors Proteins 0.000 description 1
- 102000018899 Glutamate Receptors Human genes 0.000 description 1
- 108010027915 Glutamate Receptors Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 238000006736 Huisgen cycloaddition reaction Methods 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 244000000054 animal parasite Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940104542 bravecto Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical class C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- UXOLDCOJRAMLTQ-UTCJRWHESA-N ethyl (2z)-2-chloro-2-hydroxyiminoacetate Chemical compound CCOC(=O)C(\Cl)=N\O UXOLDCOJRAMLTQ-UTCJRWHESA-N 0.000 description 1
- RJYPOWRKMKNFHH-UHFFFAOYSA-N ethyl 2,4-dimethylbenzoate Chemical compound CCOC(=O)C1=CC=C(C)C=C1C RJYPOWRKMKNFHH-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N methyl tert-butyl ether Substances COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 150000008048 phenylpyrazoles Chemical class 0.000 description 1
- 230000001242 postsynaptic effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- LIDDYRSXVNQGSP-UHFFFAOYSA-N propyl 2,4-dimethylbenzoate Chemical compound CCCOC(=O)C1=CC=C(C)C=C1C LIDDYRSXVNQGSP-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/18—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/307—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域Technical Field
本发明属于有机合成技术领域,具体涉及一种异噁唑啉宠物用杀虫剂氟雷拉纳中间体及其制备方法。The invention belongs to the technical field of organic synthesis, and particularly relates to an isoxazoline pet insecticide flurellan intermediate and a preparation method thereof.
背景技术Background Art
新型兽药氟雷拉纳(Fluralaner)作为异噁唑啉类化合物,是一类针对猫﹑狗等动物体内外寄生虫的高效杀虫剂。化学名称为4,5-[(3,5-二氯苯基)-4,5-二氢-5-三氟甲基-3-异唑基]-2-甲基-氮-[2-氧代-2-[(2,2,2-三氟乙基)氨基]乙基]-苯甲酰胺。日本日产化学工业株式会社成功合成氟雷拉纳。氟雷拉钠由英特威公司申请上市,2014年,美国食品与药品监督管理局批准氟雷拉纳在欧美市场销售(商品名Bravecto),季度销售额达1亿美元。氟雷拉纳通过拮抗γ-氨基丁酸受体和谷氨酸受体门控氯离子通道,使氯离子无法渗透进入突触后膜,干扰神经系统的跨膜信号传递,导致昆虫神经系统紊乱,进而死亡。与传统的苯基吡唑类,环戊二烯类和大环内酯类等动物杀虫剂相比较而言,氟雷拉纳在分子结构、作用位点、选择性以及交互抗性等方面均有者显著的差异,具有对哺乳动物副作用小,除了对动物寄生虫外,对大多数农业害虫同样具有较好的杀虫活性,有望成为新型农药,市场前景巨大。Fluralaner, a new veterinary drug, is an isoxazoline compound and a highly effective insecticide for parasites inside and outside the body of animals such as cats and dogs. Its chemical name is 4,5-[(3,5-dichlorophenyl)-4,5-dihydro-5-trifluoromethyl-3-isoxazolyl]-2-methyl-nitrogen-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-benzamide. Nissan Chemical Industries, Ltd. of Japan successfully synthesized Fluralaner. Fluralaner was applied for listing by Intervet. In 2014, the U.S. Food and Drug Administration approved Fluralaner for sale in the European and American markets (trade name Bravecto), with quarterly sales of $100 million. Fluralaner antagonizes the chloride ion channels gated by γ-aminobutyric acid receptors and glutamate receptors, preventing chloride ions from penetrating into the postsynaptic membrane, interfering with the transmembrane signal transmission of the nervous system, causing disorders in the insect nervous system and death. Compared with traditional animal insecticides such as phenylpyrazoles, cyclopentadienes and macrolides, flurellana has significant differences in molecular structure, site of action, selectivity and cross-resistance. It has few side effects on mammals and has good insecticidal activity against most agricultural pests except animal parasites. It is expected to become a new type of pesticide with huge market prospects.
目前氟雷拉纳的合成主要有两种方法,一种如专利WO2005085216/WO2009080250报道,以2-甲基-4-甲醛肟基苯甲酸甲酯1为原料用NCS氧化制得氯肟化合物2;2再与1,3-二氯-5-(1-三氟甲基-乙烯基)苯3进行1,3偶极环加成反应得到产物4,后经水解反应,与2-胺基-N-三氟乙基乙酰胺6缩合反应得到氟雷拉纳7。反应式如路线一所示:There are two main methods for the synthesis of flurellanine at present. One method, as reported in patent WO2005085216/WO2009080250, uses 2-methyl-4-formaldehyde oxime benzoic
路线一中,原料2-甲基-4-甲醛肟基苯甲酸甲酯1不容易制备得到,造成生产成本极高。In
另外一种合成方法如专利CN113512007A所报道,1-(3,5-二氯苯基)-三氟乙酰酮8和4-乙酰基-2-甲基苯甲腈9和碱作用下发生加成反应制备得10;10发生消除反应得到(Z)-4-(3-(3,5-二氯苯基)-4,4,4-三氟丁-2-烯酮基)-2-甲基-苯甲腈11,11再与羟胺盐酸盐发生环加成反应得到产物12。后经水解反应,与2-胺基-N-三氟乙基乙酰胺6缩合反应得到氟雷拉纳7。反应式如路线二所示:Another synthesis method is reported in patent CN113512007A, where 1-(3,5-dichlorophenyl)-trifluoroacetyl ketone 8 and 4-acetyl-2-methylbenzonitrile 9 react with a base to produce 10; 10 undergoes an elimination reaction to produce (Z)-4-(3-(3,5-dichlorophenyl)-4,4,4-trifluorobut-2-enone)-2-methyl-
线路二:Route 2:
路线二中,原料8和9也不容易制得,这条路线也存在成本高的缺陷。In route 2, raw materials 8 and 9 are also not easy to prepare, and this route also has the disadvantage of high cost.
因此,开发一条原料易得,反应条件温和、绿色环保及成本低廉的合成氟雷拉纳的工艺路线势在必行。Therefore, it is imperative to develop a process route for synthesizing flurana with readily available raw materials, mild reaction conditions, environmental protection and low cost.
发明内容Summary of the invention
本发明所要解决的技术问题是针对现有技术的现状,提供一种制备反应条件温和、绿色环保及成本低廉的氟雷拉纳中间体的制备方法,为大规模制备氟雷拉纳提供可能。The technical problem to be solved by the present invention is to provide a preparation method of a flurellane intermediate with mild reaction conditions, environmental protection and low cost in view of the current status of the prior art, so as to make it possible to prepare flurellane on a large scale.
本发明解决上述技术问题所采用的技术方案如下:The technical solution adopted by the present invention to solve the above technical problems is as follows:
本发明提供一种异噁唑啉宠物用杀虫剂氟雷拉纳中间体,其结构为如下结构式中的任意一种:The present invention provides an isoxazoline pet insecticide flurellan intermediate, the structure of which is any one of the following structural formulas:
式中HY为氢氟酸、氢氯酸、氢溴酸、氢碘酸、醋酸、三氟醋酸、甲酸、硫酸、磷酸中的至少一种或多种的混合物;Wherein HY is a mixture of at least one or more of hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, acetic acid, trifluoroacetic acid, formic acid, sulfuric acid, and phosphoric acid;
式中R为H,C1~C17的饱和脂肪烃基、脂环烃基,或者其中Z为H、F、Cl、Br、C1~C17的饱和脂肪烃基。Wherein R is H, a C1-C17 saturated aliphatic hydrocarbon group or alicyclic hydrocarbon group, or Wherein Z is H, F, Cl, Br, or a C1-C17 saturated aliphatic hydrocarbon group.
本发明提供上述的异噁唑啉宠物用杀虫剂氟雷拉纳中间体的制备方法,合成路线如下:The present invention provides a method for preparing the above-mentioned isoxazoline pet insecticide flurellan intermediate, and the synthetic route is as follows:
式中X为Cl、Br、I;Wherein X is Cl, Br, I;
式中R为H,C1~C17的饱和脂肪烃基、脂环烃基,或者其中Z为H、F、Cl、Br、C1~C17的饱和脂肪烃基;Wherein R is H, a C1-C17 saturated aliphatic hydrocarbon group or alicyclic hydrocarbon group, or Wherein Z is H, F, Cl, Br, or a C1-C17 saturated aliphatic hydrocarbon group;
式中HY为氢氟酸、氢氯酸、氢溴酸、氢碘酸、醋酸、三氟醋酸、甲酸、硫酸、磷酸中的至少一种或多种的混合物。In the formula, HY is a mixture of at least one or more of hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, acetic acid, trifluoroacetic acid, formic acid, sulfuric acid, and phosphoric acid.
所述异噁唑啉宠物用杀虫剂氟雷拉纳中间体的具体制备步骤如下:The specific preparation steps of the isoxazoline pet insecticide flurellana intermediate are as follows:
步骤一,选择性卤代反应:将原料I(2,4-二甲基苯甲酸酯)、卤代试剂和引发剂在有机溶剂中反应得到中间体I和中间体II;
步骤二,选择性酰胺化反应:将中间体I和中间体II混合,所得混合物溶于有机溶剂中,再加入碱和原料Ⅱ充分反应得到中间体III;Step 2, selective amidation reaction: Intermediate I and Intermediate II are mixed, the resulting mixture is dissolved in an organic solvent, and a base is added to react with raw material II to obtain intermediate III;
步骤三,N-去保护及成盐反应:将中间体III与含HY的有机溶剂混合物反应得到中间体IV;
步骤四,游离化反应:将中间体IV与碱在有机溶剂中反应,然后过滤得到中间体V。Step 4, ionization reaction: reacting intermediate IV with a base in an organic solvent, and then filtering to obtain intermediate V.
进一步地,步骤一中,所述的卤代试剂包括但不限于单质溴、氯气、N-碘代丁二酰亚胺(NIS)、N-溴代丁二酰亚胺(NBS)、N-氯代丁二酰亚胺(NCS)、溴化钠/溴酸钠/酸、碘化钠/碘酸钠/酸的混合物中的至少一种。Furthermore, in
进一步地,步骤一中,所述的引发剂包括但不限于偶氮二异丁腈、过氧化苯甲酰、过氧叔丁醇、过氧叔丁醚中的一种或多种混合物。Furthermore, in
进一步地,步骤一中,所述的有机溶剂包括但不限于苯、二氯甲烷、三氯甲烷、四氯化碳、1,2-二氯乙烷、1,3-二氯乙烷、乙腈、乙酸乙酯、乙酸丙酯、乙酸丁酯、四氢呋喃、乙醚、二异丙醚、石油醚、甲基叔丁基醚、1,4-二氧六环、乙二醇二甲醚中的一种或多种混合物。Furthermore, in
进一步地,步骤一中,原料I与引发剂的物质的量的比例为100:1~1:0.8;原料I与卤代试剂的物质的量的比例为10:1~1:10;反应温度为0~120℃,反应时间为10~20h。Furthermore, in
进一步地,步骤二中,中间体I和中间体II混合物中只有中间体I和大位阻原料II发生选择性酰胺化反应。Furthermore, in step 2, in the mixture of intermediate I and intermediate II, only intermediate I and the bulky steric hindrance raw material II undergo selective amidation reaction.
进一步地,步骤二中,所述的碱包括但不限于氢氧化钠、氢氧化钾、氢氧化铯、醋酸钾、醋酸钠、醋酸铯、碳酸钾、碳酸钠、碳酸铯、氢化钠、氢化钾、叔丁醇钾、叔丁醇钠、碳酸氢钾、碳酸氢钠、磷酸钠、氟化钾、磷酸钾、磷酸氢钠、磷酸氢钾、三乙胺、吡啶、二异丙基乙基胺和N-甲基吗啡啉中的一种或多种混合物。Further, in step 2, the base includes but is not limited to sodium hydroxide, potassium hydroxide, cesium hydroxide, potassium acetate, sodium acetate, cesium acetate, potassium carbonate, sodium carbonate, cesium carbonate, sodium hydride, potassium hydride, potassium tert-butoxide, sodium tert-butoxide, potassium bicarbonate, sodium bicarbonate, sodium phosphate, potassium fluoride, potassium phosphate, sodium hydrogen phosphate, potassium hydrogen phosphate, triethylamine, pyridine, diisopropylethylamine and one or more mixtures of N-methylmorpholine.
进一步地,步骤二中,所述的有机溶剂包括但不限于苯、甲苯、邻二甲苯、对二甲苯、2,4,6-三甲苯、氯苯、氟苯、二氯甲烷、二氯乙烷、乙腈、二甲基亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、乙酸乙酯、乙酸甲酯、乙酸丙酯、乙酸正丁酯、乙酸异丁酯、乙酸叔丁酯、四氢呋喃、乙醚、1,4-二氧六环、六氟异丙醇、1-甲基2-吡咯烷酮的至少一种。Furthermore, in step 2, the organic solvent includes but is not limited to at least one of benzene, toluene, o-xylene, p-xylene, 2,4,6-trimethylbenzene, chlorobenzene, fluorobenzene, dichloromethane, dichloroethane, acetonitrile, dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, ethyl acetate, methyl acetate, propyl acetate, n-butyl acetate, isobutyl acetate, tert-butyl acetate, tetrahydrofuran, ether, 1,4-dioxane, hexafluoroisopropanol, and 1-methyl 2-pyrrolidone.
进一步地,步骤二中,中间体I和中间体II混合物与碱的质量比为100:1~1:100;反应温度为-20~120℃,反应时间为8~12h。Furthermore, in step 2, the mass ratio of the mixture of intermediate I and intermediate II to the base is 100:1 to 1:100; the reaction temperature is -20 to 120° C., and the reaction time is 8 to 12 hours.
进一步地,步骤三中,所述有机溶剂包括但不限于苯、甲苯、邻二甲苯、对二甲苯、2,4,6-三甲苯、氯苯、氟苯、二氯甲烷、二氯乙烷、乙腈、二甲基亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、乙酸乙酯、乙酸甲酯、乙酸丙酯、乙酸正丁酯、乙酸异丁酯、乙酸叔丁酯、四氢呋喃、乙醚、1,4-二氧六环、六氟异丙醇、1-甲基2-吡咯烷酮的至少一种。Furthermore, in step three, the organic solvent includes but is not limited to at least one of benzene, toluene, o-xylene, p-xylene, 2,4,6-trimethylbenzene, chlorobenzene, fluorobenzene, dichloromethane, dichloroethane, acetonitrile, dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, ethyl acetate, methyl acetate, propyl acetate, n-butyl acetate, isobutyl acetate, tert-butyl acetate, tetrahydrofuran, ether, 1,4-dioxane, hexafluoroisopropanol, and 1-methyl 2-pyrrolidone.
进一步地,步骤三中,中间体III与HY的物质的量的比例为100:1~1:100。反应温度为-20~120℃,反应时间为2~6h。Furthermore, in
进一步地,步骤四中,所述的碱包括但不限于氢氧化钠、氢氧化钾、氢氧化铯、醋酸钾、醋酸钠、醋酸铯、碳酸钾、碳酸钠、碳酸铯、氢化钠、氢化钾、叔丁醇钾、叔丁醇钠、碳酸氢钾、碳酸氢钠、磷酸钠、氟化钾、磷酸钾、磷酸氢钠、磷酸氢钾、三乙胺、吡啶、二异丙基乙基胺和N-甲基吗啡啉中的一种或多种混合物。Furthermore, in step 4, the base includes but is not limited to one or more mixtures of sodium hydroxide, potassium hydroxide, cesium hydroxide, potassium acetate, sodium acetate, cesium acetate, potassium carbonate, sodium carbonate, cesium carbonate, sodium hydride, potassium hydride, potassium tert-butoxide, sodium tert-butoxide, potassium bicarbonate, sodium bicarbonate, sodium phosphate, potassium fluoride, potassium phosphate, sodium hydrogen phosphate, potassium hydrogen phosphate, triethylamine, pyridine, diisopropylethylamine and N-methylmorpholine.
进一步地,步骤四中,所述的有机溶剂包括但不限于苯、甲苯、邻二甲苯、对二甲苯、2,4,6-三甲苯、氯苯、氟苯、二氯甲烷、二氯乙烷、乙腈、二甲基亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、乙酸乙酯、乙酸甲酯、乙酸丙酯、乙酸正丁酯、乙酸异丁酯、乙酸叔丁酯、四氢呋喃、乙醚、1,4-二氧六环、六氟异丙醇、1-甲基2-吡咯烷酮的至少一种。Furthermore, in step 4, the organic solvent includes but is not limited to at least one of benzene, toluene, o-xylene, p-xylene, 2,4,6-trimethylbenzene, chlorobenzene, fluorobenzene, dichloromethane, dichloroethane, acetonitrile, dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, ethyl acetate, methyl acetate, propyl acetate, n-butyl acetate, isobutyl acetate, tert-butyl acetate, tetrahydrofuran, ether, 1,4-dioxane, hexafluoroisopropanol, and 1-methyl 2-pyrrolidone.
进一步地,步骤四中,中间体IV与碱的物质的量的比例为100:1~1:100。反应温度为-20~120℃,反应时间为4~8h。Furthermore, in step 4, the molar ratio of the intermediate IV to the base is 100:1 to 1:100. The reaction temperature is -20 to 120°C, and the reaction time is 4 to 8 hours.
本发明是以廉价易得的2,4-二甲基苯甲酸酯为原料,经过溴代,溴代产物然后与大位阻的N,O-二叔丁氧羰基-羟胺(原料II)发生选择性酰胺化反应,因邻位溴代产物即中间体Ⅱ分子中靠近反应中心的酯基占据一定的空间位置,从而影响分子反应活性的效应,使得N,O-二叔丁氧羰基-羟胺与中间体Ⅰ反应的选择性增大,在反应完成后用石油醚和乙酸乙酯(4:1)作展开剂进行简单的柱层析处理,较高收率得到2,4-二甲基苯甲酸酯对位酰胺化产物。The present invention uses cheap and readily available 2,4-dimethylbenzoate as a raw material, undergoes bromination, and the bromination product is then reacted with a large sterically hindered N,O-di-tert-butyloxycarbonyl-hydroxylamine. (Raw material II) undergoes a selective amidation reaction, because the ortho-brominated product, i.e., the ester group close to the reaction center in the intermediate II molecule occupies a certain spatial position, thereby affecting the molecular reactivity, thereby increasing the selectivity of the reaction between N,O-di-tert-butyloxycarbonyl-hydroxylamine and intermediate I. After the reaction is completed, a simple column chromatography treatment is performed using petroleum ether and ethyl acetate (4:1) as a developing solvent, and a para-amidation product of 2,4-dimethylbenzoate is obtained in a high yield.
相对于现有技术,本发明具有如下优点和有益效果:Compared with the prior art, the present invention has the following advantages and beneficial effects:
本发明提供的一种异噁唑啉宠物用杀虫剂氟雷拉纳中间体的制备方法,其不同于现有技术氟雷拉纳的合成路线中需要加入价格昂贵的反应物,本发明的制备方法具有反应工艺温和安全、绿色环保、原料廉价易得等优点,且产物的产率较高,为获得高效动物杀虫剂氟雷拉纳提供了简单便捷的制备途径,具有一定的工业化应用前景及良好的经济效益。The invention provides a method for preparing an isoxazoline pet insecticide flurella intermediate, which is different from the prior art flurella synthesis route that requires the addition of expensive reactants. The preparation method of the invention has the advantages of mild and safe reaction process, green and environmental protection, cheap and easy-to-obtain raw materials, and a high yield of the product, and provides a simple and convenient preparation route for obtaining a highly effective animal insecticide flurella, and has certain industrial application prospects and good economic benefits.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为实施例1的原料2,4-二甲基苯甲酸甲酯的核磁共振氢谱图;FIG1 is a hydrogen nuclear magnetic resonance spectrum of the raw material 2,4-dimethylbenzoate of Example 1;
图2为实施例1步骤(1)得到的中间体Ⅰ的核磁共振氢谱图;FIG2 is a hydrogen nuclear magnetic resonance spectrum of the intermediate I obtained in step (1) of Example 1;
图3为实施例1步骤(1)得到的中间体Ⅱ的核磁共振氢谱图;FIG3 is a hydrogen nuclear magnetic resonance spectrum of the intermediate II obtained in step (1) of Example 1;
图4为实施例1步骤(2)得到的中间体Ⅲ的核磁共振氢谱图;FIG4 is a hydrogen nuclear magnetic resonance spectrum of the intermediate III obtained in step (2) of Example 1;
图5为实施例1步骤(3)得到的中间体Ⅳ的核磁共振氢谱图;FIG5 is a hydrogen nuclear magnetic resonance spectrum of the intermediate IV obtained in step (3) of Example 1;
图6为实施例1步骤(4)得到的中间体Ⅴ的核磁共振氢谱图。FIG6 is a hydrogen nuclear magnetic resonance spectrum of intermediate V obtained in step (4) of Example 1.
具体实施例方式Specific embodiment
下面结合实施例,对本发明作进一步地详细说明,但本发明的实施方式不限于此。需指出的是,以下若有未特别详细说明之过程,均是本领域技术人员可参照现有技术实现或理解的。所用试剂或仪器未注明生产厂商者,视为可以通过市售购买得到的常规产品。The present invention is further described in detail below in conjunction with the examples, but the embodiments of the present invention are not limited thereto. It should be noted that if there are processes that are not particularly described in detail below, they can be implemented or understood by those skilled in the art with reference to the prior art. If the manufacturer of the reagents or instruments used is not indicated, they are deemed to be conventional products that can be purchased commercially.
实施例1Example 1
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸甲酯(16.4g,0.1mol),然后加入N-溴代琥珀酰亚胺(NBS,35.2g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和氯仿(200mL),在氮气氛围下加热至65℃回流12小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add methyl 2,4-dimethylbenzoate (16.4 g, 0.1 mol) to a 500 mL three-necked flask, then add N-bromosuccinimide (NBS, 35.2 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and chloroform (200 mL), and heat to 65° C. and reflux for 12 hours under a nitrogen atmosphere. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),K2CO3(13.8g,0.1mol)和THF(200mL),反应混合物在室温下反应11小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), K 2 CO 3 (13.8 g, 0.1 mol) and THF (200 mL), the reaction mixture was reacted at room temperature for 11 hours. After the reaction, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有饱和HCl气体的乙酸乙酯溶液(200mL)搅拌混合后30℃搅拌2小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(14.35g)。Step (3): The oily substance obtained in step (2) was mixed with an ethyl acetate solution (200 mL) containing saturated HCl gas and stirred at 30° C. for 2 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (14.35 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,碳酸钾(13.8g,0.1mol)和二氯甲烷(200mL),室温搅拌反应6个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(12.09g),四步总收率为61.9%。Step (4): Add the solid obtained in step (3), potassium carbonate (13.8 g, 0.1 mol) and dichloromethane (200 mL) into a 500 mL three-necked flask and stir at room temperature for 6 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (12.09 g). The total yield of the four steps is 61.9%.
图1为本实施例步骤(1)的原料2,4-二甲基苯甲酸甲酯的核磁共振氢谱图,1H NMR(400MHz,Chloroform-d)δ7.85(d,J=7.8Hz,1H),7.07(d,J=7.7Hz,2H),3.89(s,3H),2.60(s,3H),2.37(s,3H).Figure 1 is the hydrogen nuclear magnetic resonance spectrum of the raw material methyl 2,4-dimethylbenzoate in step (1) of this embodiment, 1 H NMR (400 MHz, Chloroform-d) δ7.85 (d, J = 7.8 Hz, 1H), 7.07 (d, J = 7.7 Hz, 2H), 3.89 (s, 3H), 2.60 (s, 3H), 2.37 (s, 3H).
图2为本实施例步骤(1)得到的中间体Ⅰ的核磁共振氢谱图,1H NMR(400MHz,Chloroform-d)δ7.96–7.86(m,1H),7.28(dd,J=5.9,2.3Hz,2H),4.47(s,2H),3.91(s,3H),2.62(s,3H).Figure 2 is a hydrogen nuclear magnetic resonance spectrum of the intermediate I obtained in step (1) of this example, 1 H NMR (400 MHz, Chloroform-d) δ7.96–7.86 (m, 1H), 7.28 (dd, J=5.9, 2.3 Hz, 2H), 4.47 (s, 2H), 3.91 (s, 3H), 2.62 (s, 3H).
图3为本实施例步骤(1)得到的中间体Ⅱ的核磁共振氢谱图,1H NMR(400MHz,Chloroform-d)δ7.90(d,J=8.0Hz,1H),7.29(d,J=1.5Hz,1H),7.19(dd,J=8.0,1.8Hz,1H),4.96(s,2H),3.94(s,3H),2.40(s,3H).Figure 3 is a hydrogen nuclear magnetic resonance spectrum of the intermediate II obtained in step (1) of this example, 1 H NMR (400 MHz, Chloroform-d) δ7.90 (d, J = 8.0 Hz, 1H), 7.29 (d, J = 1.5 Hz, 1H), 7.19 (dd, J = 8.0, 1.8 Hz, 1H), 4.96 (s, 2H), 3.94 (s, 3H), 2.40 (s, 3H).
图4为本实施例步骤(2)得到的中间体Ⅲ的核磁共振氢谱图,1H NMR(400MHz,DMSO-d6)δ7.86–7.78(m,1H),7.22(d,J=6.8Hz,2H),4.74(s,2H),3.82(s,3H),2.50(s,4H),1.42(d,J=1.5Hz,18H)FIG4 is a hydrogen nuclear magnetic resonance spectrum of the intermediate III obtained in step (2) of this example, 1 H NMR (400 MHz, DMSO-d6) δ7.86–7.78 (m, 1H), 7.22 (d, J = 6.8 Hz, 2H), 4.74 (s, 2H), 3.82 (s, 3H), 2.50 (s, 4H), 1.42 (d, J = 1.5 Hz, 18H)
图5为本实施例步骤(3)得到的中间体Ⅳ的核磁共振氢谱图,1H NMR(400MHz,DMSO-d6)δ11.94(s,1H),11.02(s,0H),10.42(s,1H),7.82(d,J=8.0Hz,0H),7.57–7.47(m,1H),4.32(s,1H),3.83(s,1H),2.51(s,2H).Figure 5 is a hydrogen nuclear magnetic resonance spectrum of the intermediate IV obtained in step (3) of this example, 1 H NMR (400 MHz, DMSO-d6) δ 11.94 (s, 1H), 11.02 (s, 0H), 10.42 (s, 1H), 7.82 (d, J = 8.0 Hz, 0H), 7.57–7.47 (m, 1H), 4.32 (s, 1H), 3.83 (s, 1H), 2.51 (s, 2H).
图6为本实施例步骤(4)得到的中间体Ⅴ的核磁共振氢谱图,1H NMR(400MHz,Chloroform-d)δ7.91(d,J=8.4Hz,1H),7.26–7.19(m,2H),4.03(s,2H),3.90(s,3H).Figure 6 is a hydrogen nuclear magnetic resonance spectrum of the intermediate V obtained in step (4) of this example, 1 H NMR (400 MHz, Chloroform-d) δ7.91 (d, J = 8.4 Hz, 1H), 7.26-7.19 (m, 2H), 4.03 (s, 2H), 3.90 (s, 3H).
实施例2Example 2
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸乙酯(17.8g,0.1mol),再加入N-溴代琥珀酰亚胺(NBS,35.2g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和氯仿(200mL),在氮气氛围下加热至65℃回流12小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add ethyl 2,4-dimethylbenzoate (17.8 g, 0.1 mol) to a 500 mL three-necked flask, then add N-bromosuccinimide (NBS, 35.2 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and chloroform (200 mL), and heat to 65°C under nitrogen atmosphere and reflux for 12 hours. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),三乙胺(10.12g,0.1mol)和THF(200mL),反应混合物在室温下反应11小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), triethylamine (10.12 g, 0.1 mol) and THF (200 mL), the reaction mixture was reacted at room temperature for 11 hours. After the reaction was completed, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有饱和HCl气体的乙酸乙酯溶液(200mL)搅拌混合后30℃搅拌2小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(13.82g)。Step (3): The oily substance obtained in step (2) was mixed with an ethyl acetate solution (200 mL) containing saturated HCl gas and stirred at 30° C. for 2 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (13.82 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,碳酸钾(13.8g,0.1mol)和二氯甲烷(200mL),40℃搅拌反应6个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(12.14g),四步总收率为62.2%。Step (4): Add the solid obtained in step (3), potassium carbonate (13.8 g, 0.1 mol) and dichloromethane (200 mL) into a 500 mL three-necked flask and stir at 40° C. for 6 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (12.14 g). The total yield of the four steps is 62.2%.
实施例3Example 3
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸正丙酯(19.2g,0.1mol),然后加入N-溴代琥珀酰亚胺(NBS,35.2g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和氯仿(200mL),在氮气氛围下加热至65℃回流12小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add 2,4-dimethylbenzoic acid n-propyl ester (19.2 g, 0.1 mol) to a 500 mL three-necked flask, then add N-bromosuccinimide (NBS, 35.2 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and chloroform (200 mL), and heat to 65° C. and reflux for 12 hours under a nitrogen atmosphere. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),CH3COONa(8.20g,0.1mol)和二氯乙烷(200mL),反应混合物在室温下反应11小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), CH 3 COONa (8.20 g, 0.1 mol) and dichloroethane (200 mL), the reaction mixture was reacted at room temperature for 11 hours. After the reaction, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有饱和HCl气体的乙酸乙酯溶液(200mL)搅拌混合后30℃搅拌2小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(14.90g)。Step (3): The oily substance obtained in step (2) was mixed with an ethyl acetate solution (200 mL) containing saturated HCl gas and stirred at 30° C. for 2 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (14.90 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,碳酸钾(13.8g,0.1mol)和二氯甲烷(200mL),60℃搅拌反应6个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(13.00g),四步总收率为66.7%。Step (4): Add the solid obtained in step (3), potassium carbonate (13.8 g, 0.1 mol) and dichloromethane (200 mL) into a 500 mL three-necked flask and stir at 60° C. for 6 hours. After the reaction is completed, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain an oily intermediate V (13.00 g). The total yield of the four steps is 66.7%.
实施例4Example 4
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸异丁酯(20.6g,0.1mol),然后加入N-溴代琥珀酰亚胺(NBS,35.2g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和氯仿(200mL),在氮气氛围下加热至65℃回流12小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add isobutyl 2,4-dimethylbenzoate (20.6 g, 0.1 mol) to a 500 mL three-necked flask, then add N-bromosuccinimide (NBS, 35.2 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and chloroform (200 mL), and heat to 65° C. and reflux for 12 hours under a nitrogen atmosphere. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),K2CO3(13.8g,0.1mol)和二氯甲烷(200mL),反应混合物在室温下反应10小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), K 2 CO 3 (13.8 g, 0.1 mol) and dichloromethane (200 mL), the reaction mixture was reacted at room temperature for 10 hours. After the reaction, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有饱和HCl气体的乙酸乙酯溶液(200mL)搅拌混合后30℃搅拌2小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(15.98g)。Step (3): The oily substance obtained in step (2) was mixed with an ethyl acetate solution (200 mL) containing saturated HCl gas and stirred at 30° C. for 2 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (15.98 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,碳酸钾(13.8g,0.1mol)和1,2-二氯乙烷(200mL),80℃搅拌反应6个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(14.21g),四步总收率为72.3%。Step (4): Add the solid obtained in step (3), potassium carbonate (13.8 g, 0.1 mol) and 1,2-dichloroethane (200 mL) into a 500 mL three-necked flask and stir at 80°C for 6 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (14.21 g). The total yield of the four steps is 72.3%.
实施例5Example 5
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸甲酯(16.4g,0.1mol),然后加入N-氯代琥珀酰亚胺(NCS,26.4g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和氯仿(200mL),在氮气氛围下加热至65℃回流10小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add methyl 2,4-dimethylbenzoate (16.4 g, 0.1 mol) to a 500 mL three-necked flask, then add N-chlorosuccinimide (NCS, 26.4 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and chloroform (200 mL), and heat to 65°C under nitrogen atmosphere and reflux for 10 hours. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),叔丁醇钠(9.61g,0.1mol)和THF(200mL),反应混合物在室温下反应10小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), sodium tert-butoxide (9.61 g, 0.1 mol) and THF (200 mL), the reaction mixture was reacted at room temperature for 10 hours. After the reaction was completed, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有饱和HCl气体的二氯甲烷溶液(200mL)搅拌混合后30℃搅拌2小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(14.08g)。Step (3): The oily substance obtained in step (2) was mixed with a dichloromethane solution (200 mL) containing saturated HCl gas and stirred at 30° C. for 2 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (14.08 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,碳酸钾(13.8g,0.1mol)和二氯甲烷(200mL),室温搅拌反应6个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(11.88g),四步总收率为60.9%。Step (4): Add the solid obtained in step (3), potassium carbonate (13.8 g, 0.1 mol) and dichloromethane (200 mL) into a 500 mL three-necked flask and stir at room temperature for 6 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (11.88 g). The total yield of the four steps is 60.9%.
实施例6Example 6
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸甲酯(16.4g,0.1mol),然后加入N-氯代琥珀酰亚胺(NCS,26.4g,0.2mol),过氧化苯甲酰(2.42g,0.01mol)和氯仿(200mL),在氮气氛围下加热至65℃回流13小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add methyl 2,4-dimethylbenzoate (16.4 g, 0.1 mol) to a 500 mL three-necked flask, then add N-chlorosuccinimide (NCS, 26.4 g, 0.2 mol), benzoyl peroxide (2.42 g, 0.01 mol) and chloroform (200 mL), and heat to 65° C. and reflux for 13 hours under a nitrogen atmosphere. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),K2CO3(13.8g,0.1mol)和THF(200mL),反应混合物在室温下反应10小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), K 2 CO 3 (13.8 g, 0.1 mol) and THF (200 mL), the reaction mixture was reacted at room temperature for 10 hours. After the reaction, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有饱和HCl气体的乙酸乙酯溶液(200mL)搅拌混合后10℃搅拌3小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(13.90g)。Step (3): The oily substance obtained in step (2) was mixed with an ethyl acetate solution (200 mL) containing saturated HCl gas and stirred at 10° C. for 3 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (13.90 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,碳酸钠(10.6g,0.1mol)和二氯甲烷(200mL),室温搅拌反应6个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(11.95g),四步总收率为61.3%。Step (4): Add the solid obtained in step (3), sodium carbonate (10.6 g, 0.1 mol) and dichloromethane (200 mL) into a 500 mL three-necked flask and stir at room temperature for 6 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (11.95 g). The total yield of the four steps is 61.3%.
实施例7Example 7
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸甲酯(16.4g,0.1mol),然后加入N-溴代琥珀酰亚胺(NBS,35.2g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和1,2-二氯乙烷(200mL),在氮气氛围下0℃搅拌20小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add methyl 2,4-dimethylbenzoate (16.4 g, 0.1 mol) to a 500 mL three-necked flask, then add N-bromosuccinimide (NBS, 35.2 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and 1,2-dichloroethane (200 mL), and stir at 0°C for 20 hours under a nitrogen atmosphere. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),K2CO3(13.8g,0.1mol)和THF(200mL),反应混合物在室温下反应10小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), K 2 CO 3 (13.8 g, 0.1 mol) and THF (200 mL), the reaction mixture was reacted at room temperature for 10 hours. After the reaction, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有饱和HCl气体的乙酸乙酯溶液(200mL)搅拌混合后60℃搅拌2小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(13.85g)。Step (3): The oily substance obtained in step (2) was mixed with an ethyl acetate solution (200 mL) containing saturated HCl gas and stirred at 60° C. for 2 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (13.85 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,NaOH(4.0g,0.1mol)和二氯甲烷(200mL),室温搅拌反应6个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(9.92g),四步总收率为50.9%。Step (4): Add the solid obtained in step (3), NaOH (4.0 g, 0.1 mol) and dichloromethane (200 mL) into a 500 mL three-necked flask and stir at room temperature for 6 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (9.92 g). The total yield of the four steps is 50.9%.
实施例8Example 8
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸甲酯(16.4g,0.1mol),然后加入N-溴代琥珀酰亚胺(NBS,35.2g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和1,2-二氯乙烷(200mL),在氮气氛围下加热至110℃回流12小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add methyl 2,4-dimethylbenzoate (16.4 g, 0.1 mol) to a 500 mL three-necked flask, then add N-bromosuccinimide (NBS, 35.2 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and 1,2-dichloroethane (200 mL), and heat to 110° C. and reflux for 12 hours under a nitrogen atmosphere. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),NaOH(4g,0.1mol)和THF(200mL),反应混合物在室温下反应10小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), NaOH (4 g, 0.1 mol) and THF (200 mL), the reaction mixture was reacted at room temperature for 10 hours. After the reaction was completed, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有饱和HCl气体的乙酸乙酯溶液(200mL)搅拌混合后70℃搅拌4小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(13.67g)。Step (3): The oily substance obtained in step (2) was mixed with an ethyl acetate solution (200 mL) containing saturated HCl gas and stirred at 70° C. for 4 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (13.67 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,叔丁醇钾(9.61g,0.1mol)和二氯甲烷(200mL),室温搅拌反应6个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(11.72g),四步总收率为60.1%。Step (4): Add the solid obtained in step (3), potassium tert-butoxide (9.61 g, 0.1 mol) and dichloromethane (200 mL) into a 500 mL three-necked flask and stir at room temperature for 6 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (11.72 g). The total yield of the four steps is 60.1%.
实施例9Example 9
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸甲酯(16.4g,0.1mol),然后加入N-溴代琥珀酰亚胺(NBS,35.2g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和氯仿(200mL),在氮气氛围下加热至65℃回流12小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add methyl 2,4-dimethylbenzoate (16.4 g, 0.1 mol) to a 500 mL three-necked flask, then add N-bromosuccinimide (NBS, 35.2 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and chloroform (200 mL), and heat to 65° C. and reflux for 12 hours under a nitrogen atmosphere. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),K2CO3(13.8g,0.1mol)和THF(200mL),反应混合物在室温下反应10小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), K 2 CO 3 (13.8 g, 0.1 mol) and THF (200 mL), the reaction mixture was reacted at room temperature for 10 hours. After the reaction, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有三氟醋酸(22.8g,0.2mol)的乙酸乙酯溶液(200mL)搅拌混合后100℃搅拌4小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(15.46g)。Step (3): The oily substance of step (2) was mixed with an ethyl acetate solution (200 mL) containing trifluoroacetic acid (22.8 g, 0.2 mol) and stirred at 100° C. for 4 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (15.46 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,磷酸钠(16.4g,0.1mol)和二氯甲烷(200mL),室温搅拌反应6个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(11.85g),四步总收率为60.7%。Step (4): Add the solid obtained in step (3), sodium phosphate (16.4 g, 0.1 mol) and dichloromethane (200 mL) into a 500 mL three-necked flask and stir at room temperature for 6 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (11.85 g). The total yield of the four steps is 60.7%.
实施例10Example 10
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸甲酯(16.4g,0.1mol),然后加入N-溴代琥珀酰亚胺(NBS,35.2g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和1,2-二氯乙烷(200mL),在氮气氛围下加热至65℃回流12小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add methyl 2,4-dimethylbenzoate (16.4 g, 0.1 mol) to a 500 mL three-necked flask, then add N-bromosuccinimide (NBS, 35.2 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and 1,2-dichloroethane (200 mL), and heat to 65° C. and reflux for 12 hours under a nitrogen atmosphere. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),K2CO3(13.8g,0.1mol)和THF(200mL),反应混合物在室温下反应10小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), K 2 CO 3 (13.8 g, 0.1 mol) and THF (200 mL), the reaction mixture was reacted at room temperature for 10 hours. After the reaction, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有三氟醋酸(22.8g,0.2mol)的乙醚溶液(200mL)搅拌混合后40℃搅拌6小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(15.25g)。Step (3): The oily substance of step (2) was mixed with an ether solution (200 mL) containing trifluoroacetic acid (22.8 g, 0.2 mol) and stirred at 40° C. for 6 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (15.25 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,碳酸钾(13.8g,0.1mol)和1,4-二氧六环(200mL),10摄氏度下搅拌反应8个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(12.01g),四步总收率为61.6%。Step (4): Add the solid obtained in step (3), potassium carbonate (13.8 g, 0.1 mol) and 1,4-dioxane (200 mL) into a 500 mL three-necked flask and stir at 10 degrees Celsius for 8 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (12.01 g). The total yield of the four steps is 61.6%.
实施例11
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸甲酯(16.4g,0.1mol),然后加入N-溴代琥珀酰亚胺(NBS,35.2g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和乙酸乙酯(200mL),在氮气氛围下加热至30℃回流14小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add methyl 2,4-dimethylbenzoate (16.4 g, 0.1 mol) to a 500 mL three-necked flask, then add N-bromosuccinimide (NBS, 35.2 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and ethyl acetate (200 mL), and heat to 30° C. and reflux for 14 hours under a nitrogen atmosphere. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),K2CO3(13.8g,0.1mol)和1,4-二氧六环(200mL),反应混合物在室温下反应8小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), K 2 CO 3 (13.8 g, 0.1 mol) and 1,4-dioxane (200 mL), the reaction mixture was reacted at room temperature for 8 hours. After the reaction, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有饱和HCl气体的乙酸乙酯溶液(200mL)搅拌混合后10℃搅拌2小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(13.68g)。Step (3): The oily substance obtained in step (2) was mixed with an ethyl acetate solution (200 mL) containing saturated HCl gas and stirred at 10° C. for 2 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (13.68 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,碳酸钠(10.6g,0.1mol)和二氯甲烷(200mL),室温搅拌反应4个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(10.85g),四步总收率为55.6%。Step (4): Add the solid obtained in step (3), sodium carbonate (10.6 g, 0.1 mol) and dichloromethane (200 mL) into a 500 mL three-necked flask and stir at room temperature for 4 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (10.85 g). The total yield of the four steps is 55.6%.
实施例12Example 12
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸甲酯(16.4g,0.1mol),然后加入N-溴代琥珀酰亚胺(NBS,35.2g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和二氯甲烷(200mL),在氮气氛围下置于10℃下反应20h。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add methyl 2,4-dimethylbenzoate (16.4 g, 0.1 mol) to a 500 mL three-necked flask, then add N-bromosuccinimide (NBS, 35.2 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and dichloromethane (200 mL), and react at 10° C. for 20 h under a nitrogen atmosphere. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product, which is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),K2CO3(13.8g,0.1mol)和THF(200mL),反应混合物在室温下反应10小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), K 2 CO 3 (13.8 g, 0.1 mol) and THF (200 mL), the reaction mixture was reacted at room temperature for 10 hours. After the reaction, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有饱和HCl气体的乙酸乙酯溶液(200mL)搅拌混合后100℃搅拌4小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(13.68g)。Step (3): The oily substance obtained in step (2) was mixed with an ethyl acetate solution (200 mL) containing saturated HCl gas and stirred at 100° C. for 4 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (13.68 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,碳酸钠(10.6g,0.1mol)和四氢呋喃(200mL),室温搅拌反应6个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(11.67g),四步总收率为59.8%。Step (4): Add the solid obtained in step (3), sodium carbonate (10.6 g, 0.1 mol) and tetrahydrofuran (200 mL) into a 500 mL three-necked flask and stir at room temperature for 6 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (11.67 g). The total yield of the four steps is 59.8%.
实施例13Example 13
本实施例中氟雷拉纳中间体的制备方法包括以下步骤:The preparation method of the fluororana intermediate in this embodiment comprises the following steps:
步骤(1):在500mL三口瓶中加入2,4-二甲基苯甲酸葵酯(29.04g,0.1mol),然后加入N-溴代琥珀酰亚胺(NBS,35.6g,0.2mol),偶氮二异丁腈(1.64g,0.01mol)和氯仿(200mL),在氮气氛围下加热至65℃回流14小时。反应物冷却至室温后过滤除去固体,滤液减压蒸馏脱除溶剂后得粗产物直接用于下一步。Step (1): Add 2,4-dimethylbenzoate (29.04 g, 0.1 mol) to a 500 mL three-necked flask, then add N-bromosuccinimide (NBS, 35.6 g, 0.2 mol), azobisisobutyronitrile (1.64 g, 0.01 mol) and chloroform (200 mL), and heat to 65° C. and reflux for 14 hours under a nitrogen atmosphere. After the reactant is cooled to room temperature, the solid is filtered out, and the filtrate is distilled under reduced pressure to remove the solvent to obtain a crude product that is directly used in the next step.
步骤(2):在500mL Schlenk三口瓶中加入步骤(1)所制备得到的油状物和(17.6g,10mmol),K2CO3(13.8g,0.1mol)和THF(200mL),反应混合物在室温下反应10小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物直接用于下一步。Step (2): Add the oil prepared in step (1) and (17.6 g, 10 mmol), K 2 CO 3 (13.8 g, 0.1 mol) and THF (200 mL), the reaction mixture was reacted at room temperature for 10 hours. After the reaction, the solid was removed by filtration, and the filtrate was distilled under reduced pressure to remove the solvent to obtain an oily product which was directly used in the next step.
步骤(3):将步骤(2)的油状物与含有饱和HCl气体的乙酸乙酯溶液(200mL)搅拌混合后-10℃搅拌2小时得到固体,然后过滤将固体常温减压干燥得到固体物中间体IV(24.51g)。Step (3): The oily substance obtained in step (2) was mixed with an ethyl acetate solution (200 mL) containing saturated HCl gas and stirred at -10°C for 2 hours to obtain a solid. The solid was then filtered and dried under reduced pressure at room temperature to obtain a solid intermediate IV (24.51 g).
步骤(4):在500mL三口瓶中加入步骤(3)所得固体物,碳酸钠(10.6g,0.1mol)和四氢呋喃(200mL),50℃搅拌反应6个小时。反应完后过滤除去固体,滤液减压蒸馏脱除溶剂后得油状物中间体V(22.67g),四步总收率为70.5%。Step (4): Add the solid obtained in step (3), sodium carbonate (10.6 g, 0.1 mol) and tetrahydrofuran (200 mL) into a 500 mL three-necked flask and stir at 50° C. for 6 hours. After the reaction is completed, filter to remove the solid, and distill the filtrate under reduced pressure to remove the solvent to obtain an oily intermediate V (22.67 g). The total yield of the four steps is 70.5%.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其它的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化均应为等效的置换方式,都包含在本发明的保护范围之内。The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications made without departing from the spirit and principle of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211606668.1A CN116063200A (en) | 2022-12-12 | 2022-12-12 | A kind of isoxazoline pet insecticide Freilaner intermediate and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211606668.1A CN116063200A (en) | 2022-12-12 | 2022-12-12 | A kind of isoxazoline pet insecticide Freilaner intermediate and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116063200A true CN116063200A (en) | 2023-05-05 |
Family
ID=86172485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211606668.1A Pending CN116063200A (en) | 2022-12-12 | 2022-12-12 | A kind of isoxazoline pet insecticide Freilaner intermediate and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116063200A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003090680A2 (en) * | 2002-04-23 | 2003-11-06 | Axys Pharmaceuticals, Inc. | Novel phenyl derivatives as inducers of apoptosis |
CN102149695A (en) * | 2008-07-09 | 2011-08-10 | 日产化学工业株式会社 | Process for production of isoxazoline-substituted benzoic acid amide compound |
CN106068269A (en) * | 2014-03-14 | 2016-11-02 | 伊莱利利公司 | Amino thiazine compounds |
CN108368101A (en) * | 2015-10-14 | 2018-08-03 | 百时美施贵宝公司 | Selective N R2B antagonists |
CN113461653A (en) * | 2020-03-30 | 2021-10-01 | 洛阳惠中兽药有限公司 | Method for preparing fraxidin intermediate, and preparation intermediate and application thereof |
-
2022
- 2022-12-12 CN CN202211606668.1A patent/CN116063200A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003090680A2 (en) * | 2002-04-23 | 2003-11-06 | Axys Pharmaceuticals, Inc. | Novel phenyl derivatives as inducers of apoptosis |
US20050026929A1 (en) * | 2002-04-23 | 2005-02-03 | Axys Pharmaceuticals, Inc. | Novel phenyl derivatives as inducers of apoptosis |
CN102149695A (en) * | 2008-07-09 | 2011-08-10 | 日产化学工业株式会社 | Process for production of isoxazoline-substituted benzoic acid amide compound |
CN106068269A (en) * | 2014-03-14 | 2016-11-02 | 伊莱利利公司 | Amino thiazine compounds |
CN108368101A (en) * | 2015-10-14 | 2018-08-03 | 百时美施贵宝公司 | Selective N R2B antagonists |
CN113461653A (en) * | 2020-03-30 | 2021-10-01 | 洛阳惠中兽药有限公司 | Method for preparing fraxidin intermediate, and preparation intermediate and application thereof |
Non-Patent Citations (2)
Title |
---|
CHEMICAL CATALOG SUPPLIER: ENAMINE LLC: "REGISTRY[online]", 《STN检索报告》, 29 June 2018 (2018-06-29), pages 1 - 2 * |
SEBASTIAN WERTZ ET AL.: "Metal-Free 2,2,6,6-Tetramethylpiperidin-1-yloxy Radical (TEMPO) Catalyzed Aerobic Oxidation of Hydroxylamines and Alkoxyamines to Oximes and Oxime Ethers", 《HELVETICA CHIMICA ACTA》, vol. 95, 31 December 2012 (2012-12-31), pages 1758 - 1772 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101243040B (en) | Process for the synthesis of mandipropamid and derivatives thereof | |
CN109942616A (en) | A kind of alkynyl-containing arylamide derivatives and preparation method and application thereof | |
CN116063200A (en) | A kind of isoxazoline pet insecticide Freilaner intermediate and preparation method thereof | |
CN108586527B (en) | Aryl phosphonate compound and preparation method thereof | |
CN117865869A (en) | A method for synthesizing 1-trifluoromethylindole compound using 2-alkynyl aromatic amine as raw material | |
JP5778103B2 (en) | Method for preparing 3,4-dichloro-N- (2-cyanophenyl) -5-isothiazole carboxamide | |
CN116891419A (en) | Synthesis method of amino-substituted benzamide compound | |
CN106588745B (en) | A kind of intermediate of benzophenafluconazole and its preparation method and application | |
CN103113318A (en) | New etoxazole compound, preparation method and acaricidal activity thereof | |
CN114957147A (en) | Preparation method of isoxazoline derivatives | |
WO2021142289A1 (en) | Complexes of n-heterocyclic carbenes for transition metal catalysis | |
KR20040039430A (en) | Process for producing (2-nitrophenyl)acetonitrile derivative and intermediate therefor | |
CN102140063B (en) | A kind of method synthesizing derivative of trifluoromethyl acrylic acid | |
CN109574866A (en) | A kind of preparation method of 2,6- dimethyl benzene amine long-chain compound | |
CN115636796B (en) | Preparation method of fampicin | |
CN115232019B (en) | Synthesis method of 3-acetamido benzotrifluoride compound | |
CN114181152B (en) | A kind of preparation method of arylpyrazole drug intermediate | |
CN116332906A (en) | Method for synthesizing chlorantraniliprole key intermediate and chlorantraniliprole or its derivative | |
CN106083929B (en) | A kind of tetrazolium phosphate compound and synthetic method with eelworm-killing activity | |
JP2625907B2 (en) | Preparation of pyrazole benzoates | |
WO2023248174A1 (en) | An improved process for preparation of voxelotor | |
JP2000169436A (en) | Production of benzoic acid amides | |
JP2001172216A (en) | Method for producing 4-trifluoromethoxybenzyl chloride | |
JP4013772B2 (en) | 2-Hydroxyimino-3-oxopropionitrile and process for producing the same | |
CN108610309A (en) | A kind of preparation method of piperidine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |